Tested Applications
| Positive WB detected in | COS-7 cells, COLO 320 cells |
| Positive IP detected in | COLO 320 cells |
| Positive IHC detected in | human gliomas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2400 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12331-1-AP targets ASH2L in WB, IHC, IF, IP, ChIP, ELISA applications and shows reactivity with human, mouse, monkey samples.
| Tested Reactivity | human, mouse, monkey |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3008 Product name: Recombinant human ASH2L protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 234-534 aa of BC015936 Sequence: HGYPLEHPFNKDGYRYILAEPDPHAPDPEKLELDCWAGKPIPGDLYRACLYERVLLALHDRAPQLKISDDRLTVVGEKGYSMVRASHGVRKGAWYFEITVDEMPPDTAARLGWSQPLGNLQAPLGYDKFSYSWRSKKGTKFHQSIGKHYSSGYGQGDVLGFYINLPEDTETAKSLPDTYKDKALIKFKSYLYFEEKDFVDKAEKSLKQTPHSEIIFYKNGVNQGVAYKDIFEGVYFPAISLYKSCTVSINFGPCFKYPPKDLTYRPMSDMGWGAVVEHTLADVLYHVETEVDGRRSPPWEP Predict reactive species |
| Full Name | ash2 (absent, small, or homeotic)-like (Drosophila) |
| Calculated Molecular Weight | 628 aa, 69 kDa |
| Observed Molecular Weight | 80 kDa |
| GenBank Accession Number | BC015936 |
| Gene Symbol | ASH2L |
| Gene ID (NCBI) | 9070 |
| RRID | AB_2059837 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UBL3 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for ASH2L antibody 12331-1-AP | Download protocol |
| IP protocol for ASH2L antibody 12331-1-AP | Download protocol |
| WB protocol for ASH2L antibody 12331-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ASH2L Polyclonal antibody (Cat# 12331-1-AP) has 5 citations published in Nature Communications, Molecular Cell, Cell Reports, Molecular Neurobiology, and Cancer Science. The associated research fields span cancer biology (c-Myc-driven cancer progression, hepatocellular carcinoma, endometrial cancer), RNA modification (m7G tRNA modification and oncogenic transformation), and neuroscience (neural migration and dendrite polarity via Reelin signaling). Applications cited include WB, IP, IHC, IF, and ChIP in human and mouse samples.
| Species | Application | Title |
|---|---|---|
Mol Cell METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation. | ||
Cell Rep Nuclear-localized HKDC1 promotes hepatocellular carcinoma through phosphorylating RBBP5 to upregulate H3K4me3 | ||
Mol Neurobiol WDR5-HOTTIP Histone Modifying Complex Regulates Neural Migration and Dendrite Polarity of Pyramidal Neurons via Reelin Signaling. | ||
Cancer Sci ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
|















